| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2012 | US8093389 e.g. 1-[(1-Ethyl-4-methoxy-1H-benzimidazol-6-yl)carbonyl]-6-(1H-tetrazol-5-yl)spiro[chroman-2,4'-piperidine]-4-one; acetyl CoA carboxylase inhibitors; antidiabetic, hypoglycemic agent; metabolic syndrome, fatty liver, hyperlipemia, obesity, diabetes, bulimia, malignant neoplasm or infectious diseases |
| 01/10/2012 | US8093388 3-aza spiro[5,5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/10/2012 | US8093386 Thioaryl substituted inhibitors of zinc proteases and their use |
| 01/10/2012 | US8093385 Leukotriene B4 inhibitors |
| 01/10/2012 | US8093380 Compounds with the bicyclo[4.2.1]nonane system for the treatment of Flaviviridae infections |
| 01/10/2012 | US8093377 Cephalosporin in crystalline form |
| 01/10/2012 | US8093370 siRNA targeting spleen tyrosine kinase |
| 01/10/2012 | US8093366 Dbait and standalone uses thereof |
| 01/10/2012 | US8093365 Biocompatible materials containing stable complexes method of TSG-6 and hyaluronan and method of using same |
| 01/10/2012 | US8093343 Nitric oxide-releasing diazeniumdiolated compounds |
| 01/10/2012 | US8093302 Substituted tetralins as selective estrogen receptor-β agonists |
| 01/10/2012 | US8093301 Anti-allergic agent |
| 01/10/2012 | US8093300 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 01/10/2012 | US8093299 Methods of treating bowel disorders |
| 01/10/2012 | US8093298 Methods for concomitant administration of colchicine and macrolide antibiotics |
| 01/10/2012 | US8093297 Methods for concomitant administration of colchicine and a second active agent |
| 01/10/2012 | US8093296 Methods for concomitant administration of colchicine and macrolide antibiotics |
| 01/10/2012 | US8093295 specific dissolution profile; specific particle size distribution |
| 01/10/2012 | US8093294 Bacterial infections; effective for recovering the activities of beta-lactam antibiotics; 2-ethyl-3-methylmaleic acid dimethyl ester; maleic acid derivatives and/or dihydrofuranyl derivatives |
| 01/10/2012 | US8093293 containing nondenatured plant extracts including legume and vegetable extracts having trypsin inhibitory activity and a natural or synthetic retinoid or retinol compounds |
| 01/10/2012 | US8093292 Conjugated fatty acid or alcohol, thiol-containing compound and bioavailable form of trivalent chromium; preventing metabolic dysregulation of adipocytes resulting from HIV-1 infection or chronic inflammation |
| 01/10/2012 | US8093291 Methods of using and compositions comprising tryptophan hydroxylase inhibitors |
| 01/10/2012 | US8093288 Genipin derivatives and uses thereof |
| 01/10/2012 | US8093287 Inhibitors of matrix metalloproteinases |
| 01/10/2012 | US8093286 Methods for treatment with bucindolol based on genetic targeting |
| 01/10/2012 | US8093283 Solid forms comprising (+)-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisinoline-1,3-dione, compositions thereof, and uses thereof |
| 01/10/2012 | US8093282 Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 01/10/2012 | US8093281 Indazoles as glucocorticoid receptor ligands |
| 01/10/2012 | US8093280 Methods of preparing imidazole-based compounds |
| 01/10/2012 | US8093279 Compound |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8093276 Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| 01/10/2012 | US8093275 Oxazolone and pyrrolidinone-substituted pryidine amides as P2X3 and P2X2/3 antagonists |
| 01/10/2012 | US8093274 Inhibitors of protein prenyltransferases |
| 01/10/2012 | US8093273 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
| 01/10/2012 | US8093272 Heteroaryl substituted cyclohexyl-1,4-diamine compounds |
| 01/10/2012 | US8093271 Anti-acid pharmaceutical composition in powder form and process for making it |
| 01/10/2012 | US8093270 Solid pharmaceutical composition comprising (R)-(−)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman |
| 01/10/2012 | US8093269 Alpha 7 nicotinic receptor selective ligands |
| 01/10/2012 | US8093268 Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-) |
| 01/10/2012 | US8093267 Methods of treating rheumatoid arthritis |
| 01/10/2012 | US8093266 Rho kinase inhibitors |
| 01/10/2012 | US8093265 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| 01/10/2012 | US8093263 Substituted pyrazolo [1,5-a] pyrimidines as metabotropic glutamate antagonists |
| 01/10/2012 | US8093262 Use of huperzine for disorders |
| 01/10/2012 | US8093261 Rapid release mini-tablets provide analgesia in laboratory animals |
| 01/10/2012 | US8093260 Aporphine derivatives and pharmaceutical use thereof |
| 01/10/2012 | US8093259 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]-benzamide for treatment of melanoma |
| 01/10/2012 | US8093258 Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases |
| 01/10/2012 | US8093257 [6,5]-bicyclic GPR119 G protein-coupled receptor agonists |
| 01/10/2012 | US8093256 Use of 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 01/10/2012 | US8093255 Imidazo[1,2-A]pyrimidines as orexin receptor antagonists |
| 01/10/2012 | US8093254 Aspartyl protease inhibitors |
| 01/10/2012 | US8093252 Crystalline polymorphic form of glucokinase activator |
| 01/10/2012 | US8093251 Nitrogen-containing heterocyclic compounds and thrombopoietin receptor activators |
| 01/10/2012 | US8093250 2-aminocarbonyl-pyridine derivatives |
| 01/10/2012 | US8093249 Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives |
| 01/10/2012 | US8093248 Compounds useful for the treatment of conditions associated with weight gain |
| 01/10/2012 | US8093247 Heteroaryl sulfonamides and CCR2 |
| 01/10/2012 | US8093246 potent deoxycytidine kinase inhibitors; O-linked pyrimidin-4-amine-based compounds |
| 01/10/2012 | US8093245 Anticancer agents; potent Deoxycytidine kinase inhibitors; inhibit thymidine kinase; inhibit uridine kinase; N-[3-(4-amino-5-fluoro-2-oxo-2H-pyrimidin-1-yl)-cyclopentyl]-3-bromo-benzenesulfonamide |
| 01/10/2012 | US8093244 Heteroaryl urea derivatives useful for inhibiting CHK1 |
| 01/10/2012 | US8093243 Hepatitis C virus inhibitors |
| 01/10/2012 | US8093242 Crystalline forms of a pyridine derivative |
| 01/10/2012 | US8093240 Triazole derivatives |
| 01/10/2012 | US8093239 Imidazopyridine kinase inhibitors |
| 01/10/2012 | US8093238 Fused thiazole derivatives as kinase inhibitors |
| 01/10/2012 | US8093237 Dibenzo[b,f][1,4]oxazapine compounds |
| 01/10/2012 | US8093236 administering 250 mg dosage form of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile/weekly; treats diabetes, cancer, autoimmune disorders and HIV infections |
| 01/10/2012 | US8093235 Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA |
| 01/10/2012 | US8093234 Method of increasing thymic output in HIV-negative patients by treatment with antiretroviral agents |
| 01/10/2012 | US8093233 Agent for inhibiting visceral fat accumulation |
| 01/10/2012 | US8093232 2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses |
| 01/10/2012 | US8093231 Sulfonylethyl phosphorodiamidates |
| 01/10/2012 | US8093230 Supersaturated aqueous ifosfamide compositions |
| 01/10/2012 | US8093229 Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors |
| 01/10/2012 | US8093228 Bisphosphonate formulation |
| 01/10/2012 | US8093227 Monosaccharide compounds and methods therefor |
| 01/10/2012 | US8093226 Cytostatic 7-deazapurine nucleosides |
| 01/10/2012 | US8093224 Antisense modulation of C-reactive protein expression |
| 01/10/2012 | US8093222 Methods for treating hypercholesterolemia |
| 01/10/2012 | US8093220 Combination of an HDAC inhibitor and an antimetabolite |
| 01/10/2012 | US8093219 Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
| 01/10/2012 | US8093217 For sensitizing multi-drug resistant cancer or radiation resistant cancer cells to chemotherapeutic agents |
| 01/10/2012 | US8093216 Diagnosis and classification of cancer; obtain tissue sample, lyse cells, screen lysate for expression of tumor polypeptide, presence of polypeptide indicates tumor |
| 01/10/2012 | US8093215 Method for restructuring a biological tissue comprising collagen fibrils and relative uses |
| 01/10/2012 | US8093211 Methods and pharmaceutical compositions for healing wounds |
| 01/10/2012 | US8093210 Treatment of sepsis with 5-ethyl-1-phenyl-2(1H)-pyridone |
| 01/10/2012 | US8093203 Method of enhancing fragrance by adding optically active muscone composition |
| 01/10/2012 | US8093048 Administering composition of beeswax and fatty acid-containing oil, and sterol; nutraceuticals; enhanced proliferation of hematopoietic cells and immune functions of the body |
| 01/10/2012 | US8093042 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 01/10/2012 | US8092846 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| 01/10/2012 | US8092844 Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions |
| 01/10/2012 | US8092840 Dietary supplement and a method to enhance sleep and lucid dreaming |
| 01/10/2012 | US8092838 Use of hydrogen sulfide in the treatment of eye diseases |
| 01/10/2012 | US8092837 Fibrin based glue with functionalized hydrophilic polymer protein binding agent |
| 01/10/2012 | US8092833 Compositions containing inclusion complexes |
| 01/10/2012 | US8092832 Generally linear effervescent oral fentanyl dosage form and methods of administering |
| 01/10/2012 | US8092829 Use of R-arylpropionic acids for treating illnesses with a rheumatic nature |
| 01/10/2012 | US8092828 Administering mixture of cytarabine and anthracycline |